%0 Journal Article
%T Differential effects of neurodegeneration biomarkers on subclinical cognitive decline
%A Barbara B. Bendlin
%A Cynthia M. Carlsson
%A Derek Norton
%A Erin Jonaitis
%A Henrik Zetterberg
%A Kaj Blennow
%A Lindsay R. Clark
%A Nicholas M. Vogt
%A Sanjay Asthana
%A Sterling C. Johnson
%J Archive of "Alzheimer's & Dementia : Translational Research & Clinical Interventions".
%D 2019
%R 10.1016/j.trci.2019.02.004
%X Neurodegeneration appears to be the biological mechanism most proximate to cognitive decline in Alzheimer's disease. We test whether t-tau and alternative biomarkers of neurodegeneration¡ªneurogranin and neurofilament light protein (NFL)¡ªadd value in predicting subclinical cognitive decline
%K Alzheimer's disease
%K Biomarkers
%K Cognition
%K Neurodegeneration
%K Amyloid
%K Cognitive decline
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6462765/